Background In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the
monoclonal antibodies casirivimab and imdevimab, reduced the viral load and number of …

Background Recent data suggest that complications and death from coronavirus disease
2019 (Covid-19) may be related to high viral loads. Methods In this ongoing, double-blind, …

Background REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal
antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of …

Background In a previous pooled analysis of 12 double-blind clinical studies that included
data on 6,139 patients with type 2 diabetes, treatment with sitagliptin, a dipeptidyl peptidase-4 …

Importance Easy-to-administer anti–SARS-CoV-2 treatments may be used to prevent
progression from asymptomatic infection to symptomatic disease and to reduce viral carriage. …

Cannabinoid 1 receptor (CB1R) inverse agonists are emerging as a potential obesity therapy.
However, the physiological mechanisms by which these agents modulate human energy …

Objectives: To determine the incidence of hypoglycaemia during Ramadan in Muslim subjects
with type 2 diabetes treated with a sulphonylurea. Methods: In an observational study, …

Fibrodysplasia ossificans progressiva (FOP) is a rare disease characterized by heterotopic
ossification (HO) in connective tissues and painful flare-ups. In the phase 2 LUMINA-1 trial, …

Background There is an unmet need for COVID-19 prevention in patient populations who
have not mounted or are not expected to mount an adequate immune response to complete …

The single‐ and multiple‐dose pharmacokinetics of etoricoxib, a selective inhibitor of
cyclooxygenase‐2, were examined in two clinical studies. Single‐dose pharmacokinetics—…